Whereas Ad-WT and XVir-N-31 showed no effect on the tumor growth, the combination of XVir-N-31 plus nivolumab or XVir-N-31-anti-PD-L1 treatment resulted in a significant tumor volume reduction (Figure 7). The gene discussed is CD274; the disease is neoplasm.